All News about Amgen![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Via Benzinga
![]() ![]()
Amgen's Lumakras Cuts Risk Of Progression By 34% In KRAS-Mutated Lung Cancer Patients
September 12, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
Via Benzinga
![]() ![]()
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]()
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
September 12, 2022
Via Benzinga
![]() ![]() ![]() ![]()
Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years
September 01, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|